Early Stage

When Outcomes Matter Most

When Outcomes Matter Most


Funding data not publicly available


Start Date


Close Date


Min. Goal
Max. Goal
Min. Investment


Security Type

Equity - Common

SEC Filing Type

RegD 506(c)

Year Founded



Healthcare & Pharmaceuticals

Tech Sector



Bellevue, Washington

MPIRICA is raising funds on OurCrowd through Reg D 506(c) raise. The company has developed healthcare information technology to ensure better surgical outcomes. The methodology of MPIRICA analyses surgical outcomes data and creates an insight into the actual outcomes of medical procedures. The information obtained enables patients, employers, insurers, and other healthcare stakeholders to make risk-adjusted and informed health decisions. Shakil Haroon, Chris Diede, and Michael Pine founded MPIRICA in 2014. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $334,995. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)


$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
MPIRICA on OurCrowd 2017
Platform: OurCrowd
Security Type: Equity - Common

Follow company

Follow MPIRICA on OurCrowd 2017

Buy MPIRICA's Deal Report

Warning: according to the close date for this deal, MPIRICA may no longer be accepting investments.

MPIRICA Deal Report

Get KingsCrowd’s comprehensive report on MPIRICA including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether MPIRICA is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the MPIRICA deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge